Reorg Webinar Series: Bausch’s Remedies for Potential Patent Defeat & Creditor Angst Over B+L Spin

In this webinar Reorg’s team discussed the latest events surrounding Bausch Health. We walked through a variety of topics, including the Bausch + Lomb spinoff, Xifaxan (patent trial and competition), the company’s options in light of covenant limitations, and more.

Thank you for signing up
for Reorg on the Record!